Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC) Meeting Abstract


Authors: Rathkopf, D. E.; Danila, D. C.; Chudow, J. J.; Morris, M. J.; Slovin, S. F.; Fine, S.; Fox, J. J.; Larson, S. M.; Rosen, N.; Scher, H. I.
Abstract Title: Anti-insulin-like growth factor-1 receptor (IGF-IR) monoclonal antibody cixutumumab plus mammalian target of rapamycin (mTOR) inhibitor temsirolimus in metastatic castration-resistant prostate cancer (CRPC)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 41s
Language: English
ACCESSION: WOS:000208852002242
DOI: 10.1200/jco.2010.28.15_suppl.tps242
PROVIDER: wos
Notes: Meeting Abstract: TPS242 -- S -- Source: Wos
Altmetric Score
MSK Authors
  1. Josef J Fox
    44 Fox
  2. Neal Rosen
    356 Rosen
  3. Susan Slovin
    184 Slovin
  4. Michael Morris
    274 Morris
  5. Dana Elizabeth Rathkopf
    142 Rathkopf
  6. Samson W Fine
    315 Fine
  7. Steven M Larson
    762 Larson
  8. Howard Scher
    816 Scher
  9. Daniel C Danila
    82 Danila
  10. Jay Chudow
    2 Chudow